Actuate Therapeutics ACTU
NASDAQ ACTU
$0.87 +0.09 (+12.13%)
As of: Oct 1, 2026 · 2:29 PM EDT

Actuate Therapeutics (ACTU) Preferred Stock Liabilities (2023 - 2024)

Updated

Actuate Therapeutics (ACTU) reported Preferred Stock Liabilities of $94.18 million for Q2 2024.

Analysis

Actuate Therapeutics (ACTU) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Actuate Therapeutics 18.73 Mn 18.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 94.18 Mn
Dec 31, 2023 94.18 Mn
API Access

Actuate Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ACTU&period=max&api_key=YOUR_API_KEY